Global Artificial Intelligence in Diabetes Management to register a CAGR of 33% by 2028.

The global artificial intelligence in diabetes management market was at a market value of $93m in 2021 and is projected to reach over $600m by 2028 The global market is expected to register a CAGR of 33% during the forecast period. The market report is an indispensable guide on growth factors, challenges, restraints, and opportunities in the global artificial intelligence in the diabetes management marketplace. The competitive and geographical landscape is well elaborated in the report.

Artificial Intelligence or AI is one of the best inventions, especially for the medical field. The global artificial intelligence in diabetes management market has extreme growth potential since diabetes is one of the most prevalent diseases across the globe. The idea behind incorporating AI in diabetes management is to provide error-free diabetes management care to the patients. AI in diabetes management is extensively used by patients for self-care purposes as well as the medical institutes treating diabetes.

Covid-19 witnessed a rise in the global artificial intelligence in diabetes management market mainly for self-care purposes of diabetic patients because hospitals and clinics focused more on Covid-19 patients. Since most of the world population had to make arrangements to operate from home, this propelled the demand for AI in diabetes management, especially in the self-care segment.

The global market is expected to generate high market revenues during the forecast period.

The growing geriatric population suffering from diabetes is expected to propel the global artificial intelligence in diabetes management market. Extensive R&D on different AI-enabled diabetes management by governments and key market players are expected to assist the global market growth. A rise in awareness amongst diabetic patients about the importance of proper diabetes management is a contributing factor to the global market growth. The addition of new market players across the globe along with marketing and awareness programs conducted by manufacturers of AI in diabetes management is also anticipated to assist in the global market growth.

However, lack of awareness amongst certain diabetic patients along with hesitancy towards frequent diabetes checks is likely to hamper the growth of the market. Constant advancement in the field of aligning AI and medical assistance is expected to provide growth opportunities in the global market during the projection period.

The global artificial intelligence in diabetes management market can be segmented into technique, device, and region. By technique, the market can be segmented into intelligent data analysis and case-based reasoning. By device, the market can be segmented into insulin delivery devices, glucose monitoring devices, and diagnostic devices.

North America and Europe are expected to register the highest CAGR in the global artificial intelligence in diabetes management market during the forecast period. This is following the presence of multiple AI-enabled diabetes management device manufacturers in these regions. The regions have also witnessed an increase in investment for constant up-gradation for diabetes management. The regions have registered higher diabetic patients owing to stationary lifestyles and eating habits thus contributing highly to the global market.

Asia-Pacific is expected to register a high global market share because of the rising standard of living and improving spending capacity of the population. A growing number of medical institutes offering AI in diabetes management is also expected to assist the region in its high contribution to the global market.

The Middle East with a rising population becoming health conscious and proactively taking steps for the prevention of diabetes is expected to contribute to the global artificial intelligence in the diabetes management market.

Some of the significant players in the global artificial intelligence in diabetes management market include Vodafone Group Plc, Tidepool, IBM Corporation, Google Inc., Glooko Inc., Diabnext, and Apple Inc.

Recent Developments:

Medtronic, in November 2020, introduced CGM integrated smart insulin pen on the market. The company said that the launch of the product could be integrated with Guardian Connect CGM Data.

Browse the full “Artificial Intelligence In Diabetes Management Market By Technique ( Intelligent Data Analysis And Case-Based Reasoning), By Device (Insulin Delivery Devices, Glucose Monitoring Devices, And Diagnostic Devices) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/artificial-intelligence-in-diabetes-management-market

Global artificial intelligence in the diabetes management market is segmented as follows:

By Technique

• Intelligent Data Analysis
• Case-Based Reasoning

By Device

• Insulin Delivery Devices
• Glucose Monitoring Devices
• Diagnostic Devices

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com